Anteris Technologies Global (AVR) vs. Its Rivals Financial Contrast

Anteris Technologies Global (NASDAQ:AVR) is one of 142 publicly-traded companies in the “MED INSTRUMENTS” industry, but how does it weigh in compared to its rivals? We will compare Anteris Technologies Global to related businesses based on the strength of its dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability.

Profitability

This table compares Anteris Technologies Global and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-3,944.93%	-252.71%	-169.61%
Anteris Technologies Global Competitors	-482.31%	-113.49%	-21.33%

Analyst Recommendations

This is a summary of current ratings and target prices for Anteris Technologies Global and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1	0	4	0	2.60
Anteris Technologies Global Competitors	1255	3837	7167	272	2.52

Anteris Technologies Global presently has a consensus price target of $16.50, indicating a potential upside of 302.44%. As a group, “MED INSTRUMENTS” companies have a potential upside of 7.95%. Given Anteris Technologies Global’s stronger consensus rating and higher possible upside, research analysts clearly believe Anteris Technologies Global is more favorable than its rivals.

Institutional and Insider Ownership

54.1% of shares of all “MED INSTRUMENTS” companies are owned by institutional investors. 4.5% of Anteris Technologies Global shares are owned by company insiders. Comparatively, 14.0% of shares of all “MED INSTRUMENTS” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Anteris Technologies Global and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Anteris Technologies Global	$2.70 million	-$76.29 million	-2.27
Anteris Technologies Global Competitors	$1.73 billion	$194.00 million	5.47

Anteris Technologies Global’s rivals have higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Anteris Technologies Global rivals beat Anteris Technologies Global on 9 of the 12 factors compared.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.